Search

在史上首次该类型合作中，MSK 与中国胸部肿瘤研究协作组将携手共进，共同打造一个对来自美国和中国的患者都开放的临床试验项目。

… Friday, April 19, 2019 中国胸部肿瘤研究协作组 (CTONG) 是由 20 多个中国顶尖学术癌症中心组成的联盟。Memorial Sloan Kettering 首次与 CTONG 合作，努力促成一项对中美两国患者开放的临床试验项目。 该举措将重点关注 肺癌 精准治疗的临床试验。在中美两国，肺癌都是癌症致死的头号杀手。 此次合作于去年 12 月正式启动，旨在为中美两国的多中心 临床试验 奠定学术基础，最终目标是提高临床试验参与率，推动有效的新疗法尽快获批。 合作期间还实施了其他显著措施，包括远程医疗和教育举措，旨在改善两国患者的护理状况，并努力推动行业参与。 为获得该领域的指导

While we stay home to flatten the curve of COVID-19, hardworking healthcare professionals are putting in long hours on the front lines.

… Thursday, April 23, 2020 While we stay home to flatten the curve of COVID-19, hardworking healthcare professionals are putting in long hours on the front lines. Memorial Sloan Kettering Cancer Center (MSK) is encouraging our healthcare heroes to take a moment to recharge during this challenging time.

MSK molecular geneticist and data scientist Elli Papaemmanuil is leading an initiative to identify the genomic changes that drive pediatric tumors.

… Monday, September 30, 2019 Summary About half of pediatric tumors have a significant mutation that can be identified with standard clinical tests. MSK researchers are looking for a better way to detect mutations in the rest. MSK-IMPACT ™ detects changes in more than 400 cancer-associated genes. The test

New research from MSK investigates a promising approach against diabetic retinopathy and finds patients with early-onset colorectal cancer likely don’t need more frequent surveillance colonoscopies.

… Friday, May 24, 2024 New research from Memorial Sloan Kettering Cancer Center (MSK) investigates a promising approach against diabetic retinopathy and finds patients with early-onset colorectal cancer likely don’t need more frequent surveillance colonoscopies. Anti-ceramide immunotherapy promising against

American tennis player and World No. 8 ranked James Blake will formally announce today the launch of the Thomas Blake, Sr., Memorial Research Fund, which he established to support cancer research at Memorial Sloan Kettering Cancer Center.

… Thursday, July 10, 2008 Blake Aims to Raise $1 Million for the Fund in Its Inaugural American tennis player and World No. 8 ranked James Blake will formally announce today the launch of the Thomas Blake, Sr., Memorial Research Fund, which he established to support cancer research at Memorial Sloan Kettering

Brain cancer is deadly because it’s so difficult to study. Scientist Luis Parada has developed an innovative model to analyze how brain tumors form and respond to treatment.

… Friday, January 1, 2021 Finding a treatment for brain tumors like glioblastoma (GBM) has been a heartbreaking challenge. The five-year survival rate is less than 10% for patients 45 and older. Because these tumors are relatively rare and located in such a sensitive and well-sheltered part of the body

Researchers have discovered a genetic mechanism that may trigger most childhood cancers.

… Monday, May 15, 2017 Summary Researchers have found that a gene called PGBD5 plays a role in causing many pediatric cancers by creating mutations that turn cells malignant. Cancer is primarily a disease of the aged. A person’s risk rises throughout the years as genetic mutations pile up, due either to

Memorial Sloan Kettering Cancer Center’s website has been nominated for The Webby Award, the most prestigious international award honoring excellence on the Internet. Selected from among nearly 10,000 total entries, the Center’s website is one of five nominated in the Health category.

… Thursday, April 12, 2012 Memorial Sloan Kettering Cancer Center’s website has been nominated for The Webby Award, the most prestigious international award honoring excellence on the Internet. Selected from among nearly 10,000 total entries, the Center’s website is one of five nominated in the Health

Research from the lab of cancer biologist Tuomas Tammela shows that some lung cancer cells retain a “memory” of the healthy cell where they came from — one that might be exploited to make an emerging type of lung cancer treatment called KRAS inhibition more effective.

… Friday, November 17, 2023 A new understanding of lung cancer cells’ “memories” suggests a new strategy for improving treatment, Memorial Sloan Kettering Cancer Center (MSK) researchers have found. Research from the lab of  cancer biologist Tuomas Tammela, MD, PhD shows that some lung cancer cells retain

New insights into the pathophysiology of lymphedema are providing targets for future treatment interventions to cure and prevent the disease, according to our recent research.

… Friday, June 7, 2019 New insights into the pathophysiology of lymphedema are providing targets for future treatment interventions to cure and prevent the disease, according to our recent research. Previously, it was believed that the lymphatic vasculature played a passive role by transporting antigen-presenting